Contact FutureLearn for Support
Skip main navigation
We use cookies to give you a better experience, if that’s ok you can close this message and carry on browsing. For more info read our cookies policy.
We use cookies to give you a better experience. Carry on browsing if you're happy with this, or read our cookies policy for more information.

Conclusion and support information

Drug discovery helps us to fight diseases and alleviate suffering.

To combat serious or new emerging disease (e.g. cancers and Ebola virus), an effective platform for drug discovery is necessary. Today, high throughput screening and structural biology are regarded as an essential part of drug discovery because both of them can reduce the developmental time of new drugs.

In this topic, you have learnt how these technologies are involved in EGFR drug design. We recommend you go back to review the first video again. You may have more new ideas about the drug discovery.

Supporting information

We have provided a PDF below which provides supporting information. This includes explanation of:

  1. Structural biology
  2. Yeast two-hybrid system
  3. Small compound screening

Share this article:

This article is from the free online course:

Introduction to Translational Research: Connecting Scientists and Medical Doctors

Taipei Medical University

Course highlights Get a taste of this course before you join: